Subscribe To
Algernon pharmaceuticals includes novel salt forms of dmt in its recent ip patent applications
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that it believes the company has "m...
January 24, 2022, 8:22 am
Bofa securities: there's hardly any upside in curevac this year
Shares of CureVac N.V. (NASDAQ: CVAC) closed nearly 15% down on Friday after BofA Securities said there isn't much in the books this year for sharehol...
January 21, 2022, 4:28 pm
Bofa securities: there's hardly any upside in curevac this year
Shares of CureVac N.V. (NASDAQ: CVAC) closed nearly 15% down on Friday after BofA Securities said there isn't much in the books this year for sharehol...
January 21, 2022, 4:28 pm
Bofa securities: there's hardly any upside in curevac this year
Shares of CureVac N.V. (NASDAQ: CVAC) closed nearly 15% down on Friday after BofA Securities said there isn't much in the books this year for sharehol...
January 21, 2022, 4:28 pm
Hepion pharmaceuticals: facing the momentous year 2022
Hepion begins the crucial year 2022, where it will finally be determined whether CRV431 possesses anti-fibrotic/anti-inflammatory activity in NASH pat...
January 21, 2022, 12:37 pm
Hepion pharmaceuticals: facing the momentous year 2022
Hepion begins the crucial year 2022, where it will finally be determined whether CRV431 possesses anti-fibrotic/anti-inflammatory activity in NASH pat...
January 21, 2022, 12:37 pm
Hepion pharmaceuticals: facing the momentous year 2022
Hepion begins the crucial year 2022, where it will finally be determined whether CRV431 possesses anti-fibrotic/anti-inflammatory activity in NASH pat...
January 21, 2022, 12:37 pm
Why this analyst has increased confidence in inovio pharmaceuticals
Following the recent pullback in Inovio pharmaceuticals Inc.'s (NASDAQ:INO) shares, the stock valuation...
January 21, 2022, 11:50 am
Why this analyst has increased confidence in inovio pharmaceuticals
Following the recent pullback in Inovio pharmaceuticals Inc.'s (NASDAQ:INO) shares, the stock valuation...
January 21, 2022, 11:50 am
Why this analyst has increased confidence in inovio pharmaceuticals
Following the recent pullback in Inovio pharmaceuticals Inc.'s (NASDAQ:INO) shares, the stock valuation...
January 21, 2022, 11:50 am
Alnylam' reveals detailed 18-month data from vutrisiran trial in inherited disease
Alnylam pharmaceuticals Inc (NASDAQ: ALNY) has announced detailed data from HELIOS-A Phase 3 study o...
January 21, 2022, 9:23 am
Alnylam' reveals detailed 18-month data from vutrisiran trial in inherited disease
Alnylam pharmaceuticals Inc (NASDAQ: ALNY) has announced detailed data from HELIOS-A Phase 3 study o...
January 21, 2022, 9:23 am
Alnylam' reveals detailed 18-month data from vutrisiran trial in inherited disease
Alnylam pharmaceuticals Inc (NASDAQ: ALNY) has announced detailed data from HELIOS-A Phase 3 study o...
January 21, 2022, 9:23 am
Apollon formularies names dr archibald mcdonald as clinical trials director
Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...
January 21, 2022, 7:57 am
Apollon formularies names dr archibald mcdonald as clinical trials director
Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...
January 21, 2022, 7:57 am
Apollon formularies names dr archibald mcdonald as clinical trials director
Apollon Formularies PLC (AQSE:APOL) said it appointed Dr Archibald McDonald as its director of clinical trials. McDonald is a surgeon and has served i...
January 21, 2022, 7:57 am
Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023
ASLAN pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging...
January 21, 2022, 6:36 am
Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023
ASLAN pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging...
January 21, 2022, 6:36 am
Aslan pharma kickstarts mid-stage atopic dermatitis trial, data expected in 2023
ASLAN pharmaceuticals Ltd (NASDAQ: ASLN) has screened the first patient in its Phase 2b dose-ranging...
January 21, 2022, 6:36 am
Opiant pharma starts dosing in opnt002 mid-stage study for alcohol use disorder
Opiant pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first patient in Phase 2 trial of OPNT002, n...
January 21, 2022, 5:56 am